1. An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator
    Li-Juan Liu et al, 2015, J. Med. Chem. CrossRef
  2. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents
    V. F. Chekhun et al, 2016, Ukr.Biochem.J. CrossRef
  3. Cancer cells with irons in the fire
    Laura M. Bystrom et al, 2015, Free Radical Biology and Medicine CrossRef
  4. null
    Sudabeh Motamed et al, 2017 CrossRef
  5. Effect of the FE 2+ chelation by 2,2′-dipyridyl in the doxorubicin-induced lethality in breast tumor cell lines
    Jéssica R. Bernardes et al, 2017, Life Sciences CrossRef
  6. Conversion of human fibroblasts into functional cardiomyocytes by small molecules
    Nan Cao et al, 2016, Science CrossRef
  7. High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
    Khuloud Bajbouj et al, 2018, Technol Cancer Res Treat CrossRef
  8. The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers
    Sandrine Tury et al, 2018, J. Pathol. CrossRef
  9. Iron in the Tumor Microenvironment—Connecting the Dots
    Christa Pfeifhofer-Obermair et al, 2018, Front. Oncol. CrossRef
  10. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
    Christopher J. Greene et al, 2018, Free Radical Biology and Medicine CrossRef
  11. Iron as a Central Player and Promising Target in Cancer Progression
    Michaela Jung et al, 2019, IJMS CrossRef
  12. Brain iron loading impairs DNA methylation and alters GABAergic function in mice
    Qi Ye et al, 2019, The FASEB Journal CrossRef
  13. The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases
    Martin Roatsch et al, 2019, ACS Chem. Biol. CrossRef
  14. Macrophage iron homeostasis and polarization in the context of cancer
    Michaela Jung et al, 2015, Immunobiology CrossRef
  15. null
    Steven G. Gray, 2015 CrossRef
  16. Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells
    Melanie R. Power Coombs et al, 2015, Experimental and Molecular Pathology CrossRef
  17. Therapeutic Effect of Deferrioxamine Conjugated to PEGylated Gold Nanoparticles and Complexed with Mn(II) Beside the CT Scan and MRI Diagnostic Studies
    Fatemeh Yaghoobi et al, 2019, Colloids and Surfaces A: Physicochemical and Engineering Aspects CrossRef
  18. Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
    Christina Mertens et al, 2016, PLoS ONE CrossRef
  19. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
    Anna L. Greenshields et al, 2019, Biometals CrossRef
  20. Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
    Anne-Sophie Hamy et al, 2019, OncoImmunology CrossRef
  21. Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma
    Darya S Nesterova et al, 2020 CrossRef
  22. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
    Rikki A. M. Brown et al, 2020, Front. Oncol. CrossRef
  23. Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562
    Nianyi Li et al, 2017, Oncotarget CrossRef
  24. Inosine 5′-diphosphate, a molecular decoy rescues Nucleoside diphosphate kinase from c-MYC G-Quadruplex unfolding
    Pallabi Sengupta et al, 2020, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  25. Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival
    Jibran Sualeh Muhammad et al, 2020, Epigenetics CrossRef
  26. Iron alters Ca 2+ homeostasis in doxorubicin‐resistant K562 cells
    Leman Yalcintepe et al, 2020, Clin Exp Pharmacol Physiol CrossRef
  27. Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications
    Kuo-Feng Hsu et al, 2020, Epigenetics CrossRef
  28. Iron: An Essential Element of Cancer Metabolism
    Myriam Y. Hsu et al, 2020, Cells CrossRef
  29. Metabolic Control of m6A RNA Modification
    Joohwan Kim et al, 2021, Metabolites CrossRef
  30. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
    Shiyao Sui et al, 2021, Pharmacology & Therapeutics CrossRef
  31. Iron deprivation restrains the differentiation and pathogenicity of T helper 17 cell
    Lin Li et al, 2021, J Leukoc Biol CrossRef
  32. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
    Emilie Logie et al, 2021, IJMS CrossRef